Xarelto Side Effect Lawsuit

Xarelto Lawsuit

Dangerous Drug Lawsuit

The medical device defect and dangerous drug side effect law firm of Nadrich & Cohen, LLP, is currently pursuing Xarelto side effect claims.

Our drug side effect attorneys handle claims where a Xarelto patient sustained a serious and uncontrolled, internal bleed. In some instances, the internal bleed can be so severe that death results. Most frequently, the uncontrolled bleed occurs in one of the following areas of the body:

  • Gastrointestinal Tract
  • Urogenital Tract
  • Cerebral Area
  • Rectal Area
We are also investigating claims for patients, who suffered the following side effects while using Xarelto, or shortly thereafter:

The above side effects can occur, even with first dosing of Xarelto. Therefore, long-term use of Xarelto is not necessary in order to make a Xarelto Side Effect Claim.  We believe that Janssen, the manufacturer of Xarelto, failed to adequately warn consumers and patients of potential Xarelto side effects.

Xarelto was widely marketed by Janssen as a convenient blood thinner that did not require blood monitoring, as commonly required for use of other blood thinning medications.  We believe that blood monitoring should have been required, in order to evaluate the clotting effect of Xarelto. Hip implant and knee implant patients have an increased risk of developing blood clots in the days following implantation. Given that Xarelto is prescribed for medical device implant patients, blood monitoring is of increased importance in the days following the implant procedure.

If you or a loved one have suffered one of the above side effects while taking Xarelto , or shortly thereafter, contact our drug side effects attorneys immediately to discuss your possible claim. We will provide a free consultation. Simply call 1-800-718-4658, or complete the contact form on this page. We promise that a member of our Xarelto Side Effect Team will respond to your request, within 24 hours. Call today, don’t wait!

Learn More...

October 27, 2016

Kidney Damage Associated with Nexium, Prevacid and Prilosec Use

Nexium, Prilosec & Prevacid: Quick Relief But Kidney Damage? Most of us hav...

October 11, 2016

FDA Requires Black Box Warning for Hepatitis C Drugs

Just a few years ago, there was no cure for hepatitis C. Patients had to live w...

November 4, 2011

Chantix Side Effects Include Suicide Risk Says Study

A new study on Chantix side effects suggests a link between Chantix and suicide ...

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.


What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.


Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

October 15, 2019

Zantac Recalled In All Markets

GlaxoSmithKline said on October 8, 2019 that it was recalling their popular heartburn medication Zantac in all markets as a precaution. This comes mere days after the U.S. Food and Drug Administration (FDA) found “unacceptable” levels of the carcinogen NDMA in the medicine.

October 2, 2019

Hidden FDA Database Concealed Reports of Surgical Stapler Malfunctions

A hidden FDA database of medical device failures was shut down in June 2019. The database contains medical device reports submitted to the FDA via its Alternative Summary Reporting Program from 1999 to 2019. Reports which were sent to this database were not, until recently, made public. The Alternative Summary Reporting Program is a non-public database, unlike the FDA’s MAUDE database which publicly logs medical device failures or defects for public review.


We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.